Ligand Pharmaceuticals (NASDAQ:LGND) Trading Down 8.8%

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) shares dropped 8.8% during trading on Tuesday . The company traded as low as $79.97 and last traded at $80.21. Approximately 82,870 shares were traded during trading, a decline of 47% from the average daily volume of 156,157 shares. The stock had previously closed at $87.91. Analysts […]

Related Keywords

Switzerland ,Swiss ,Andrew Reardon ,Nancy Ryan Gray ,Barclays Plc ,Hightower Advisors ,Ligand Pharmaceuticals Incorporated ,Securities Exchange Commission ,News Ratings For Ligand Pharmaceuticals Daily ,Swiss National Bank ,Victory Capital Management Inc ,Ligand Pharmaceuticals Stock Down ,Charles Schwab Investment Management Inc ,Institutional Investors Weigh In On Ligand Pharmaceuticals ,Ligand Pharmaceuticals ,Get Free Report ,Pharmaceuticals Stock Down ,Director Nancy Ryan Gray ,Exchange Commission ,Capital Management ,National Bank ,Schwab Investment Management ,Tower Advisors ,Pharmaceuticals Incorporated ,Ligand Pharmaceuticals Daily ,